Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text
Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text,Revisiting the PD-1 pathway | Science Advances,Reduced irradiation exposure areas enhanced anti-tumor effect by inducing DNA damage and preserving lymphocytes | Molecular Medicine | Full Text,Revisiting the PD-1 pathway | Science Advances,Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text